These celebrities with HIV are proving that you can thrive and enjoy life after an HIV diagnosis. Here, their hopes for ...

More than 50% of HIV diagnoses now occur in 48 counties in the United States. Cuyahoga County, home to Cleveland, is one of ...

Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...

USAID antimalarial and HIV supplies valued at nearly $140 million were delayed in the first half of the year or not delivered at all due to the Trump administration’s foreign aid pause, The Post found ...

Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating-and possibly even ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even ...

Attributing the rise in infections to increased testing, health officials said around 23 percent of those potentially living with HIV remain unaware of their health status.

Gilead Sciences, Inc. (NASDAQ:GILD) ranks among the most undervalued NASDAQ stocks to buy now. Citing momentum in Gilead ...

The slashing of foreign aid and closure of HIV programmes earlier this year is continuing to impact people living with HIV, writes Nick Ferris in Nairobi, causing serious damage to long-term efforts t ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...